|
Suarez Rodriguez B, Guzman Herrador BR, Diaz Franco A, Sanchez-Seco Farinas MP, Del Amo Valero J, Aginagalde Llorente AH, de Agreda JPAP, Malonda RC, Castrillejo D, Chirlaque Lopez MD, Chong Chong EJ, Balbuena SF, Garcia VG, Garcia-Cenoz M, Hernandez LG, Montalban EG, Carril FG, Cortijo TG, Bueno SJ, Sanchez AL, Linares Dopido JA, Lorusso N, Martins MM, Martinez Ochoa EM, Mateo AM, Pena JM, Anton AIN, Otero Barros MT, Martinez MDCP, Jimenez PP, Martin OP, Rivas Perez AI, Garcia MS, Response Group NM, Soria FS, Sierra Moros MJ. Epidemiologic Features and Control Measures during Monkeypox Outbreak, Spain, June 2022. Emerg Infect Dis. 2022 Sep;28(9):1847-1851. doi: 10.3201/eid2809.221051. Epub 2022 Jul 12. PubMed PMID: 35820165; PubMed Central PMCID: PMC9423914.
AÑO: 2022; IF: 11.8
|
35820165
|
Cirera L, Ballesta M, Arana BM, Chirlaque MD; por el Grupo de Trabajo de Mortalidad de la Sociedad Espanola de Epidemiologia. [Professional and activities profiles heterogeneity in the mortality registries in Spain]. Gac Sanit. 2022 Nov-Dec;36(6):553-556. doi: 10.1016/j.gaceta.2022.04.001. Epub 2022 May 28. Spanish. PubMed PMID: 35637055.
AÑO: 2022; IF: 1.9
|
|
Canete A, Peris-Bonet R, Capocaccia R, Pardo-Romaguera E, Segura V, Munoz-Lopez A, Fernandez-Teijeiro A, Galceran-Padros J, Gatta G; Spanish Neuroblastoma Linkage Working Group (SpNbLinkWG). Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries - A study by the Joint Action on Rare Cancers. Cancer Epidemiol. 2022 Jun;78:102145. doi: 10.1016/j.canep.2022.102145. Epub 2022 Mar 25. PubMed PMID: 35344745.
AÑO: 2022; IF: 2.6
|
|
Smith-Byrne K., Cerani A., Guida F., Zhou S., Agudo A., Aleksandrova K., Barricarte A., Barranco M.R., Bochers C.H., Gram I.T., Han J., Amos C.I., Hung R.J., Grankvist K., Nøst T.H., Imaz L., Chirlaque-López M.D., Johansson M., Kaaks R., Kühn T., Martin R.M., McKay J.D., Pala V., Robbins H.A., Sandanger T.M., Schibli D., Schulze M.B., Travis R.C., Vineis P., Weiderpass E., Brennan P., Johansson M., Richards J.B. Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements. Cancer Epidemiology Biomarkers and Prevention. October 2022. 31:1966-1974. 10.1158/1055-9965.EPI-21-1033
AÑO: 2022; IF: 3.8
|
|
Kolijn PM, Hosnijeh FS, Spath F, Hengeveld PJ, Agathangelidis A, Saleh M, Casabonne D, Benavente Y, Jerkeman M, Agudo A, Barricarte A, Besson C, Sanchez MJ, Chirlaque MD, Masala G, Sacerdote C, Grioni S, Schulze MB, Nieters A, Engelfriet P, Hultdin M, McKay JD, Vermeulen RCH, Langerak AW. High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood. 2022 Mar 10;139(10):1557-1563. doi: 10.1182/blood.2021012890. PubMed PMID: 34662377; PubMed Central PMCID: PMC10650964.
AÑO: 2022; IF: 20.3
|